<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2022-3159</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-3159</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>Альтернативные сосудистые доступы в условиях электрофизиологических операционных: фокус на качество жизни пациентов в раннем послеоперационном периоде</article-title><trans-title-group xml:lang="en"><trans-title>Alternative vascular accesses in electrophysiological operating rooms: focus on the quality of life in the early postoperative period</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6624-046X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдуллаев</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Abdullaev</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аслан Мурадович Абдуллаев — аспирант отдела нарушений сердечного ритма и проводимости.</p><p>Москва, Тел.: +7 (903) 480-53-00</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">abdullaevaslanm@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3788-3997</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Давтян</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Davtyan</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карапет Владимирович Давтян — доктор медицинских наук, доцент, зав. отделом нарушений сердечного ритма и проводимости.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">doctordavtyan@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6855-4857</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Харлап</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kharlap</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Сергеевна Харлап — кандидат медицинских наук, старший научный сотрудник отдела нарушений сердечного ритма и проводимости.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">kharlapmaria@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>04</day><month>06</month><year>2022</year></pub-date><volume>21</volume><issue>5</issue><fpage>3159</fpage><lpage>3159</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Абдуллаев А.М., Давтян К.В., Харлап М.С., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Абдуллаев А.М., Давтян К.В., Харлап М.С.</copyright-holder><copyright-holder xml:lang="en">Abdullaev A.M., Davtyan K.V., Kharlap M.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/3159">https://cardiovascular.elpub.ru/jour/article/view/3159</self-uri><abstract><p>Фибрилляция предсердий является наиболее распространенным нарушением сердечного ритма, заболеваемость которой увеличивается параллельно с прогрессирующим старением населения. Фибрилляция предсердий ухудшает прогноз пациентов и значительно снижает качество жизни. Совершенствование технических и методических аспектов катетерных процедур приводит к их широкому внедрению в клиническую практику как с целью профилактики эмболических осложнений, так и в тактике контроля ритма. Необходимость обеспечения доступов к магистральным сосудам, чаще к бедренным венам, использование интродьюсеров большого диаметра, а также агрессивных режимов антитромботической терапии в послеоперационном периоде выводит на первый план локальные осложнения катетерных процедур и диктует необходимость сохранения пациентами горизонтального положения тела для достижения стабильного гемостаза. Использование ультразвуковой визуализации позволяет снизить количество сосудистых осложнений до минимальных значений. Однако длительная иммобилизация нередко ведет к развитию болевого синдрома в спине, задержке мочеиспускания, развитию инфекционных осложнений, что больше выражено в популяции пациентов старшего возраста. С целью снижения времени иммобилизации были разработано множество систем для гемостаза, не лишенных недостатков и требующих дополнительных расходов на лечение пациента. В этой связи разработка и внедрение в клиническую практику новых видов сосудистого доступа для улучшения качества жизни в раннем послеоперационном периоде видится актуальным. С данной целью проводится рандомизированное исследование, в котором сравниваются эффективность и безопасность дистального бедренного доступа, позволяющего активизировать пациентов в наиболее ранние сроки после операции.</p></abstract><trans-abstract xml:lang="en"><p>Atrial fibrillation is the most common arrhythmia, the incidence of which increases in parallel with the progressive aging of the population. Atrial fibrillation worsens the prognosis of patients and significantly reduces the quality of life. Improvement of the technical and methodological aspects of catheter procedures leads to their widespread introduction into clinical practice both for the prevention of embolic events and for rhythm control. The need to provide access to the main vessels, more often to the femoral veins, the use of large bore introducers, as well as aggressive regimens of antithrombotic therapy in the postoperative period, bring to the fore local complications of catheter procedures and necessitates to maintain a horizontal position to achieve stable hemostasis. The use of ultrasound imaging can significantly reduce the number of vascular events. However, long-term immobilization often leads to back pain, urinary retention, and infectious complications, which is more pronounced in the older patient population. In order to reduce the immobilization time, many hemostasis systems have been developed, which have disadvantages and require additional costs for the treatment of patients. In this regard, the development and introduction into clinical practice of novel vascular access types to improve the quality of life in the early postoperative period seems relevant. For this purpose, a randomized study is conducted, which compares the efficacy and safety of the distal femoral access, which makes it possible to activate patients as soon as possible after surgery.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фибрилляция предсердий</kwd><kwd>качество жизни</kwd><kwd>катетерная аблация</kwd><kwd>радиочастотная аблация</kwd><kwd>криобаллонная изоляция устьев легочных вен</kwd><kwd>имплантация окклюзирующего устройства ушка левого предсердия</kwd><kwd>антикоагулянтная терапия</kwd><kwd>ультразвуковое исследование</kwd><kwd>сосудистые осложнения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atrial fibrillation</kwd><kwd>quality of life</kwd><kwd>catheter ablation</kwd><kwd>radiofrequency ablation</kwd><kwd>cryoballoon pulmonary vein isolation</kwd><kwd>left atrial appendage occlusion</kwd><kwd>anticoagulant therapy</kwd><kwd>ultrasound</kwd><kwd>vascular complications</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/ Paisley study. Heart. 2001;86(5):516-21. doi:10.1136/heart.86.5.516.</mixed-citation><mixed-citation xml:lang="en">Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/ Paisley study. Heart. 2001;86(5):516-21. doi:10.1136/heart.86.5.516.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Go AS, Hylek EM, Phillips KA, et al. Prevalence of Diagnosed Atrial Fibrillation in Adults National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5. doi:10.1001/jama.285.18.2370.</mixed-citation><mixed-citation xml:lang="en">Go AS, Hylek EM, Phillips KA, et al. Prevalence of Diagnosed Atrial Fibrillation in Adults National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5. doi:10.1001/jama.285.18.2370.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Conen D. Epidemiology of atrial fibrillation. Eur Heart J. 2018;39(16):1323-4. doi:10.1161/CIRCRESAHA.120.316340.</mixed-citation><mixed-citation xml:lang="en">Conen D. Epidemiology of atrial fibrillation. Eur Heart J. 2018;39(16):1323-4. doi:10.1161/CIRCRESAHA.120.316340.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Schnabel RB, Yin X, Larson MG, et al. Fifty-Year Trends in Atrial Fibrillation Prevalence, Incidence, Risk Factors, and Mortality in the Community Renate. Lancet. 2015;386(9989):154-62. doi:10.1016/S0140-6736(14)61774-8.</mixed-citation><mixed-citation xml:lang="en">Schnabel RB, Yin X, Larson MG, et al. Fifty-Year Trends in Atrial Fibrillation Prevalence, Incidence, Risk Factors, and Mortality in the Community Renate. Lancet. 2015;386(9989):154-62. doi:10.1016/S0140-6736(14)61774-8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Thrall G, Lane D, Carroll D, Lip GYH. Quality of Life in Patients with Atrial Fibrillation: A Systematic Review. Am J Med. 2006;119(5):448.e1-19. doi:10.1016/j.amjmed.2005.10.057.</mixed-citation><mixed-citation xml:lang="en">Thrall G, Lane D, Carroll D, Lip GYH. Quality of Life in Patients with Atrial Fibrillation: A Systematic Review. Am J Med. 2006;119(5):448.e1-19. doi:10.1016/j.amjmed.2005.10.057.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: A Swedish nationwide long-term casecontrol study. Eur Heart J. 2013;34(14):1061-7. doi:10.1093/eurheartj/ehs469.</mixed-citation><mixed-citation xml:lang="en">Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995-2008: A Swedish nationwide long-term casecontrol study. Eur Heart J. 2013;34(14):1061-7. doi:10.1093/eurheartj/ehs469.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-Year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359-64. doi:10.1016/S0002-9343(02)01236-6.</mixed-citation><mixed-citation xml:lang="en">Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-Year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359-64. doi:10.1016/S0002-9343(02)01236-6.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart S, Murphy N, Walker A, et al. Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart. 2004;90(3):286-92. doi: 10.1136/hrt.2002.008748.</mixed-citation><mixed-citation xml:lang="en">Stewart S, Murphy N, Walker A, et al. Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart. 2004;90(3):286-92. doi: 10.1136/hrt.2002.008748.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kim MH, Johnston SS, Chu BC, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the united states. Circ Cardiovasc Qual Outcomes. 2011;4(3):313-20. doi:10.1161/CIRCOUTCOMES.110.958165.</mixed-citation><mixed-citation xml:lang="en">Kim MH, Johnston SS, Chu BC, et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the united states. Circ Cardiovasc Qual Outcomes. 2011;4(3):313-20. doi:10.1161/CIRCOUTCOMES.110.958165.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Колбин А. С., Мосикян А. А., Татарский Б. А. Социальноэкономическое бремя фибрилляции предсердий в России: динамика за 7 лет (2010-2017 годы). Вестник аритмологии. 2018;(92):42-8. doi:10.25760/VA-2018-92-42-48.</mixed-citation><mixed-citation xml:lang="en">Kolbin AS, Mosikyan AA, Tatarsky BA. Socioeconomic burden of atrial fibrillations in Russia: seven-year trends (20102017). Journal of Arrhythmology. 2018;(92):42-8. (In Russ.) doi:10.25760/VA-2018-92-42-48.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Asad ZUIA, Yousif A, Khan MS, et al. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ: Arrhythmia Electrophysiol. 2019;12(9):1-13. doi:10.1161/CIRCEP.119.007414.</mixed-citation><mixed-citation xml:lang="en">Asad ZUIA, Yousif A, Khan MS, et al. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Circ: Arrhythmia Electrophysiol. 2019;12(9):1-13. doi:10.1161/CIRCEP.119.007414.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Imberti JF, Ding WY, Kotalczyk A, et al. Catheter ablation as firstline treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107(20):1630-6. doi:10.1136/heartjnl-2021-319496.</mixed-citation><mixed-citation xml:lang="en">Imberti JF, Ding WY, Kotalczyk A, et al. Catheter ablation as firstline treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107(20):1630-6. doi:10.1136/heartjnl-2021-319496.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Richter S, Di Biase L, Hindricks G. Atrial fibrillation ablation in heart failure. Eur Heart J. 2019;40(8):663-72. doi:10.1093/eurheartj/ehy778.</mixed-citation><mixed-citation xml:lang="en">Richter S, Di Biase L, Hindricks G. Atrial fibrillation ablation in heart failure. Eur Heart J. 2019;40(8):663-72. doi:10.1093/eurheartj/ehy778.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention. 2016;11(10):1170-9. doi:10.4244/EIJY15M01_06.</mixed-citation><mixed-citation xml:lang="en">Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention. 2016;11(10):1170-9. doi:10.4244/EIJY15M01_06.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Reddy VY, Doshi SK, Kar S, et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70(24):2964-75. doi:0.1016/j. jacc.2017.10.021.</mixed-citation><mixed-citation xml:lang="en">Reddy VY, Doshi SK, Kar S, et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70(24):2964-75. doi:0.1016/j. jacc.2017.10.021.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cappato R, Calkins H, Chen S-A, et al. Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation. Circulation. 2005;111:1100-5. doi:10.1161/01.CIR.0000157153.30978.67.</mixed-citation><mixed-citation xml:lang="en">Cappato R, Calkins H, Chen S-A, et al. Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation. Circulation. 2005;111:1100-5. doi:10.1161/01.CIR.0000157153.30978.67.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Tonchev IR, Nam MCY, Gorelik A, et al. Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: a systematic review and meta-analysis. EP Europace. 2021;23(7):1024-32. doi:10.1093/europace/euaa415.</mixed-citation><mixed-citation xml:lang="en">Tonchev IR, Nam MCY, Gorelik A, et al. Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: a systematic review and meta-analysis. EP Europace. 2021;23(7):1024-32. doi:10.1093/europace/euaa415.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA — J Am Med Assoc. 2019;321(13):1261-74. doi:10.1001/jama.2019.0693.</mixed-citation><mixed-citation xml:lang="en">Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA — J Am Med Assoc. 2019;321(13):1261-74. doi:10.1001/jama.2019.0693.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ibáñez Criado JL, Quesada A, Cózar R, et al. Spanish Catheter Ablation Registry. 18th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2018). Rev Esp Cardiol. 2019;72(12):1031-42. doi:10.1016/j.rec.2019.08.005.</mixed-citation><mixed-citation xml:lang="en">Ibáñez Criado JL, Quesada A, Cózar R, et al. Spanish Catheter Ablation Registry. 18th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2018). Rev Esp Cardiol. 2019;72(12):1031-42. doi:10.1016/j.rec.2019.08.005.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bertaglia E, Zoppo F, Tondo C, et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: A multicenter prospective registry on procedural safety. Hear Rhythm. 2007;4(10):1265-71. doi:10.1016/j.hrthm.2007.06.016.</mixed-citation><mixed-citation xml:lang="en">Bertaglia E, Zoppo F, Tondo C, et al. Early complications of pulmonary vein catheter ablation for atrial fibrillation: A multicenter prospective registry on procedural safety. Hear Rhythm. 2007;4(10):1265-71. doi:10.1016/j.hrthm.2007.06.016.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Samuel M, Abrahamowicz M, Joza J, et al. Population-level evaluation of complications after catheter ablation in patients with atrial fibrillation and heart failure. J Cardiovasc Electrophysiol. 2019;30(12):2678-85. doi:10.1111/jce.14202.</mixed-citation><mixed-citation xml:lang="en">Samuel M, Abrahamowicz M, Joza J, et al. Population-level evaluation of complications after catheter ablation in patients with atrial fibrillation and heart failure. J Cardiovasc Electrophysiol. 2019;30(12):2678-85. doi:10.1111/jce.14202.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol. 2008;19(6):627-31. doi:10.1111/j.1540-8167.2008.01181.x.</mixed-citation><mixed-citation xml:lang="en">Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: Incidence and predictors. J Cardiovasc Electrophysiol. 2008;19(6):627-31. doi:10.1111/j.1540-8167.2008.01181.x.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Deshmukh A, Patel NJ, Pant S, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: Analysis of 93 801 procedures. Circulation. 2013;128(19):2104-12. doi:10.1161/CIRCULATIONAHA.113.003862.</mixed-citation><mixed-citation xml:lang="en">Deshmukh A, Patel NJ, Pant S, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: Analysis of 93 801 procedures. Circulation. 2013;128(19):2104-12. doi:10.1161/CIRCULATIONAHA.113.003862.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">De Greef Y, Ströker E, Schwagten B, et al. Complications of pulmonary vein isolation in atrial fibrillation: Predictors and comparison between four different ablation techniques: Results from the MIddelheim PVI-registry. Europace. 2018;20(8):127986. doi:10.1093/europace/eux233.</mixed-citation><mixed-citation xml:lang="en">De Greef Y, Ströker E, Schwagten B, et al. Complications of pulmonary vein isolation in atrial fibrillation: Predictors and comparison between four different ablation techniques: Results from the MIddelheim PVI-registry. Europace. 2018;20(8):127986. doi:10.1093/europace/eux233.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ha ACT, Wijeysundera HC, Birnie DH, et al. Real-world outcomes, complications, and cost of catheter-based ablation for atrial fibrillation: An update. Curr Opin Cardiol. 2017;32(1):47-52. doi:10.1097/HCO.0000000000000348.</mixed-citation><mixed-citation xml:lang="en">Ha ACT, Wijeysundera HC, Birnie DH, et al. Real-world outcomes, complications, and cost of catheter-based ablation for atrial fibrillation: An update. Curr Opin Cardiol. 2017;32(1):47-52. doi:10.1097/HCO.0000000000000348.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Yamagata K, Wichterle D, Roubíček T, et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: A multicentre randomized efficacy and safety trial (ULTRA-FAST trial). Europace. 2018;20(7):1107-14. doi:10.1093/europace/eux175.</mixed-citation><mixed-citation xml:lang="en">Yamagata K, Wichterle D, Roubíček T, et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: A multicentre randomized efficacy and safety trial (ULTRA-FAST trial). Europace. 2018;20(7):1107-14. doi:10.1093/europace/eux175.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kupó P, Pap R, Sághy L, et al. Ultrasound guidance for femoral venous access in electrophysiology procedures — systematic review and meta-analysis. J Interv Card Electrophysiol. 2020;59(2):407-14. doi:10.1007/s10840-019-00683-z.</mixed-citation><mixed-citation xml:lang="en">Kupó P, Pap R, Sághy L, et al. Ultrasound guidance for femoral venous access in electrophysiology procedures — systematic review and meta-analysis. J Interv Card Electrophysiol. 2020;59(2):407-14. doi:10.1007/s10840-019-00683-z.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Calkins H, Hindricks G, Cappato R, Kim YH, et al. 2017 HRS/ EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace. 2018;20(1):157-208. doi:10.1093/europace/eux275.</mixed-citation><mixed-citation xml:lang="en">Calkins H, Hindricks G, Cappato R, Kim YH, et al. 2017 HRS/ EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. Europace. 2018;20(1):157-208. doi:10.1093/europace/eux275.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Arai H, Mizukami A, Hanyu Y, et al. Risk factors for venous bleeding complication at the femoral puncture site after catheter ablation of atrial fibrillation. J Arrhythmia. 2020;36(4):678-84. doi:10.1002/joa3.12378.</mixed-citation><mixed-citation xml:lang="en">Arai H, Mizukami A, Hanyu Y, et al. Risk factors for venous bleeding complication at the femoral puncture site after catheter ablation of atrial fibrillation. J Arrhythmia. 2020;36(4):678-84. doi:10.1002/joa3.12378.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001;90(1-2):191-9. doi:10.1016/S03043959(00)00403-6.</mixed-citation><mixed-citation xml:lang="en">Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001;90(1-2):191-9. doi:10.1016/S03043959(00)00403-6.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Bode K, Breithardt OA, Kreuzhuber M, et al. Patient discomfort following catheter ablation and rhythm device surgery. Europace. 2015;17(7):1129-35. doi:10.1093/europace/euu325.</mixed-citation><mixed-citation xml:lang="en">Bode K, Breithardt OA, Kreuzhuber M, et al. Patient discomfort following catheter ablation and rhythm device surgery. Europace. 2015;17(7):1129-35. doi:10.1093/europace/euu325.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wongrakpanich S, Wongrakpanich A, Melhado K, et al. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143-50. doi:10.14336/AD.2017.0306.</mixed-citation><mixed-citation xml:lang="en">Wongrakpanich S, Wongrakpanich A, Melhado K, et al. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143-50. doi:10.14336/AD.2017.0306.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Lehman AB, Ahmed AS, Patel PJ. Avoiding urinary catheterization in patients undergoing atrial fibrillation catheter ablation. J Atr Fibrillation. 2020;12(4):4-7. doi:10.4022/jafib.2221.</mixed-citation><mixed-citation xml:lang="en">Lehman AB, Ahmed AS, Patel PJ. Avoiding urinary catheterization in patients undergoing atrial fibrillation catheter ablation. J Atr Fibrillation. 2020;12(4):4-7. doi:10.4022/jafib.2221.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kashefi C, Messer K, Barden R, et al. Incidence and Prevention of Iatrogenic Urethral Injuries. J Urol. 2008;179(6):2254-8. doi:10.1016/j.juro.2008.01.108.</mixed-citation><mixed-citation xml:lang="en">Kashefi C, Messer K, Barden R, et al. Incidence and Prevention of Iatrogenic Urethral Injuries. J Urol. 2008;179(6):2254-8. doi:10.1016/j.juro.2008.01.108.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Cluckey A, Perino AC, Fan J, et al. Urinary tract infection after catheter ablation of atrial fibrillation. PACE — Pacing Clin Electrophysiol. 2019;42(7):951-8. doi:10.1111/pace.13738.</mixed-citation><mixed-citation xml:lang="en">Cluckey A, Perino AC, Fan J, et al. Urinary tract infection after catheter ablation of atrial fibrillation. PACE — Pacing Clin Electrophysiol. 2019;42(7):951-8. doi:10.1111/pace.13738.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Baldini G, Bagry H, Aprikian A Carli F. Postoperative Urinary Retention. Anesthesiology. 2009;110:1139-57. doi:10.1097/ALN.0b013e31819f7aea.</mixed-citation><mixed-citation xml:lang="en">Baldini G, Bagry H, Aprikian A Carli F. Postoperative Urinary Retention. Anesthesiology. 2009;110:1139-57. doi:10.1097/ALN.0b013e31819f7aea.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Mohanty S, Trivedi C, Beheiry S, et al. Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: A multicentre experience on efficacy and complications. Europace. 2019;21(7):1048-54. doi:10.1093/europace/euz004.</mixed-citation><mixed-citation xml:lang="en">Mohanty S, Trivedi C, Beheiry S, et al. Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: A multicentre experience on efficacy and complications. Europace. 2019;21(7):1048-54. doi:10.1093/europace/euz004.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Richter RP, Law MA, Borasino S, et al. Distal Superficial Femoral Vein Cannulation for Peripherally Inserted Central Catheter Placement in Infants with Cardiac Disease. Congenit Heart Dis. 2016;11(6):733-40. doi:10.1177/11297298211011867.</mixed-citation><mixed-citation xml:lang="en">Richter RP, Law MA, Borasino S, et al. Distal Superficial Femoral Vein Cannulation for Peripherally Inserted Central Catheter Placement in Infants with Cardiac Disease. Congenit Heart Dis. 2016;11(6):733-40. doi:10.1177/11297298211011867.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Wan Y, Chu Y, Qiu Y, et al. The feasibility and safety of PICCs accessed via the superficial femoral vein in patients with superior vena cava syndrome. J Vasc Access. 2018;19(1):34-9. doi:10.5301/jva.5000810.</mixed-citation><mixed-citation xml:lang="en">Wan Y, Chu Y, Qiu Y, et al. The feasibility and safety of PICCs accessed via the superficial femoral vein in patients with superior vena cava syndrome. J Vasc Access. 2018;19(1):34-9. doi:10.5301/jva.5000810.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao L, Cao X, Wang Y. Cannulation of the superficial femoral vein at mid-thigh when catheterization of the superior vena cava system is contraindicated. J Vasc Access. 2020;21(4):524-8. doi:10.1177/1129729819896473.</mixed-citation><mixed-citation xml:lang="en">Zhao L, Cao X, Wang Y. Cannulation of the superficial femoral vein at mid-thigh when catheterization of the superior vena cava system is contraindicated. J Vasc Access. 2020;21(4):524-8. doi:10.1177/1129729819896473.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
